INE939A01011
INE939A01011
STRIDES PHARMA SCI LTD
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 100.04B EUR | 100.76B EUR | 86.43B EUR |
Enterprise Value | 115.99B EUR | 100.76B EUR | 102.13B EUR |
Valuation Multiples | |||
Trailing P/E | 16.31x | 17.21x | 16.92x |
Forward P/E | 11.38x | -- | -- |
Price to Sales | 2x | 2.05x | 1.79x |
Price to Book | 3.22x | -- | 2.78x |
EV/Revenue | 2.32x | 2.05x | 2.12x |
EV/EBITDA | 14.14x | 9.58x | 9.71x |
Price to FCF (P/FCF) | -- | -- | -- |
EV/FCF | -- | -- | -- |
FCF Yield | -- | -- | -- |